# BENDAMUSTINE HYDROCHLORIDE

NDC: 10019-079
Generic name: bendamustine hydrochloride
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20221215

FDA application: NDA216078

## Active ingredients

- BENDAMUSTINE HYDROCHLORIDE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10019-079"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10019-079
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=766b73e2-49bb-47f9-bbb1-44cfa1a3197e